Name
SEEDSUPPLY INC.
What We Do
Our core expertise lies in Improved Affinity Selection Mass Spectrometry, a proprietary technology that enables direct binding analysis of membrane proteins in their native state, without solubilization. This is a game-changer in drug discovery, as it preserves the natural conformation and function of SLC transporters, GPCRs, and other critical yet challenging drug targets, allowing for more physiologically relevant screening. Beyond membrane proteins, SEEDSUPPLY also performs large-scale binding protein screening with over 17,000 proteins, offering a powerful platform to uncover novel drug targets and mechanisms of action. Combined with our unique library of 400,000 compounds, this enables unparalleled efficiency in target determination and lead compound identification, even for previously undruggable targets.
Founded
May 2017
Website
Address
26-1, Muraoka-Higashi 2-Chome
Fujisawa, Kanagawa 2510012
Japan
Fujisawa, Kanagawa 2510012
Japan